Leprosy

Hunter's Tropical Medicine and Emerging Infectious Disease: Ninth Edition

Volumn , Issue , 2012, Pages 519-524

  Lockwood, Diana N J ^a,b   Lambert, Saba ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902070294     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4390-4.00057-6     Document Type: Chapter

References (24)

1. Walker SL, Lockwood DN Leprosy. Clin Dermatol 2007, 25:165-172.
2. World Health Organization Leprosy Update 2011. Weekly Epidemiological Record No. 36 2011, 86:389-400.
3. Cole ST, Eiglmeier K, Parkhill J, et al. Massive gene decay in the leprosy bacillus. Nature 2001, 409:1007-1011.
4. Davey TF, Rees RJW The nasal discharge in leprosy: clinical and bacteriological aspects. Lepr Rev 1974, 45:135-144.
5. Brandsma JW, Yoder Land Macdonald M Leprosy acquired by inoculation from a knee injury. Lepr Rev 2005, 76:175-179.
6. Desikan KV, Sreevatsa Extended studies on the viability of M. leprae outside the human body. Lepr Rev 1995, 66:287-295.
7. Britton WJ, Lockwood DNJ Leprosy. Lancet 2004, 363:1209-1219.
8. Lyon S, Lyon AC, Castorina Da Silva R, et al. A comparison of ML Flow serology and slit skin test smears to assess the bacterial load in newly diagnosed leprosy patients in Brazil. Leprosy Review 2008, 79:162-170.
9. Ridley DS, Jopling WH Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966, 34:255-273.
10. Deshpande J, Chougule SG, Thakar UH, Revankar CR Rate of relapse and reactions in MB leprosy patients after 24 and 12 months of MDT in Maharashtra. Indian J Lepr 2004, 76:229-230.
11. Van Brakel WH, Khawas IB Nerve damage in leprosy: an epidemiological and clinical study of 396 patients in west Nepal-Part 1. Definitions, methods and frequencies. Lepr Rev 1994, 65:204-221.
12. Sandor Rao PSS, Sugamaran DST, Richard J, Smith WCS Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy. Lepr Rev 2006, 77:25-33.
13. Pocaterra L, Jain S, Reddy R, et al. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg 2006, 74:868-879.
14. Richardus JH, Withington SG, Anderson AM, et al. Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials. Lepr Rev 2003, 74:319-327.
15. Setia MS, Steinmaus C, Ho CS, et al. The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis 2006, 6:162-170.
16. Moet FJ, Pahan D, Oskam L, Richardus JH Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. BMJ 2008, 336:761-764.
17. Kawuma HJS, Bwire R, Adatu-Engwau F Leprosy and infection with the human immunodeficency virus in Uganda.; a case-control study. Int J Lepr 1994, 62:521-526.
18. Lienhardt C, Kamate B, Jamet P, et al. Effect of HIV infection on leprosy: a three year survey in Bamako, Mali. Int J Lepr Other Mycobact Dis 1996, 64:383-391.
19. Sekar B, Jayasheela M, Chattopadhya D, et al. Prevalence of HIV Infection and high-risk characteristics among leprosy patients of South India; a case-control study. Int J Lepr 1994, 62:527-531.
20. Sampaio EP, Caneshi JRT, Nery JAC, et al. Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus infected individuals. Infect Immun 1995, 63:18848-18854.
21. Deps PD, Lockwood DNJ Leprosy occurring as immune reconstitution syndrome. Trans R Soc Trop Med Hyg 2008, 102:966-968.
22. Ustianowski AP, Lawn SD, Lockwood DNJ Interactions between HIV infection and leprosy: a paradox. Lancet Infect Dis 2006, 6:350-360.
23. Marlowe SN, Hawksworth RA, Butlin CR, et al. Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy type 1 reactions in Nepal. Trans R Soc Trop Med Hyg 2004, 98:602-609.
24. Marlowe SN, Leekassa R, Bizuneh E, et al. Response to ciclosporin treatment in Ethiopian and Nepali patients with severe leprosy Type 1 reactions. Trans R Soc Trop Med Hyg 2007, 101:1004-1012.